ASK1ng to Delay the Progression of Pulmonary Fibrosis

Am J Respir Cell Mol Biol. 2022 May;66(5):465-467. doi: 10.1165/rcmb.2022-0026ED.

Authors

Michael Schuliga^{1

2}, Satish K Madala^{3

4}

Affiliations

¹ College of Health, Medicine and Wellbeing.
² School of Biomedical Sciences and Pharmacy The University of Newcastle Callaghan, New South Wales, Australia.
³ Department of Pediatrics University of Cincinnati College of Medicine Cincinnati, Ohio.
⁴ Division of Pulmonary Medicine Cincinnati Children's Hospital Medical Center Cincinnati, Ohio.

No abstract available

Publication types

Editorial
Research Support, N.I.H., Extramural
Comment

MeSH terms

Bleomycin / adverse effects
Humans
Myofibroblasts / pathology
Pulmonary Fibrosis* / pathology
p38 Mitogen-Activated Protein Kinases

Substances

Bleomycin
p38 Mitogen-Activated Protein Kinases

Grants and funding